Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: TEXAS BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-08-30 to 2024-08-31
Current total value of award: $99990.6
Description: IN VITRO AND IN VIVO STUDY OF ROC-325 AND ITS ANALOGS IN LIVE SARS-COV-2 MODELS